[[4-(1,4,5,6-TETRAHYDRO-4-METHYL-6-OXO-3- -PYRIDAZINYL)PHENYL]HYDRAZONO]PROPANEDINITRILE OR THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR THE MEDICAMENT PREPARATION

[[4-(1,4,5,6-TETRAHYDRO-4-METHYL-6-OXO-3- -PYRIDAZINYL)PHENYL]HYDRAZONO]PROPANEDINITRILE OR THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF FOR THE MEDICAMENT PREPARATION

There is disclosed [[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo- -3-pyridazinyl)phenyl]hydrazono]propanedinitrile, or the pharmaceutically acceptable salts thereof, which has been previously suggested for the treatment of congestive heart failure and for the preparation of a medicament useful in the treat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HONKANEN ERKKI J, HAIKALA HEIMO O, BACKSTROM REIJO J, NORE PENTTI T, LEVIJOKI JOUKO M
Format: Patent
Sprache:eng ; slo
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There is disclosed [[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo- -3-pyridazinyl)phenyl]hydrazono]propanedinitrile, or the pharmaceutically acceptable salts thereof, which has been previously suggested for the treatment of congestive heart failure and for the preparation of a medicament useful in the treatment of myocardial ischemia.